Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-006478

CONCERT PHARMACEUTICALS, INC. · CNCE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jan 30, 2018
Accepted (ET)
Feb 1, 2018 · 4:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367920

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2,F3Jan 30, 2018S5,000$21.33D6,946ISee Footnote
Common StockF4,F3Jan 31, 2018S4,700$20.78D2,246ISee Footnote
Common StockF5,F3Jan 31, 2018S300$21.29D1,946ISee Footnote
Common StockF3Feb 1, 2018S1,946$19.99D0ISee Footnote
Common Stockholding———286,975D
Common StockF6holding———44,351ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses